HighTower Advisors, LLC - CELSUS THERAPEUTICS PLC ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CELSUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2014$66,000
-63.1%
13,742
-53.3%
0.00%
-66.7%
Q3 2014$179,000
-3.8%
29,400
-2.0%
0.00%0.0%
Q2 2014$186,00030,0000.00%
Other shareholders
CELSUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 286,508$166,0000.02%
MORGAN STANLEY 8$00.00%
UBS Group AG 3,350$2,0000.00%
Citadel Advisors 15,249$9,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 600$348,0000.00%
View complete list of CELSUS THERAPEUTICS PLC shareholders